PepGen P-15 and PepGen P-15 Flow (2015-05-04) — recall 53185
Health Canada — Medical Devices · Canada · 2015-06-01 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: FDA released a safety communication on January 21, 2015 regarding the use of bone graft substitutes containing recombinant proteins or synthetic peptides in patients under age 18. In response to this communication, the warning for the PepGen products will be updated to include a statement indicating product is not for use in patients under the age of 18.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.